Progress with rotavirus vaccines: Summary of the Tenth International Rotavirus Symposium

Expert Review of Vaccines

Volumn 12, Issue 2, 2013, Pages 113-117

  Parashar, Umesh ^a   Steele, Duncan ^b   Neuzil, Kathleen ^c   Quadros, Ciro De ^d   Tharmaphornpilas, Piyanit ^e   Serhan, Fatima ^f   Santosham, Mathu ^g   Patel, Manish ^a   Glass, Roger ^h  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b BILL AND MELINDA GATES FOUNDATION   (United States)

^c Program for Appropriate Technology in Health   (United States)

^d SABIN VACCINE INSTITUTE   (United States)

^e MINISTRY OF PUBLIC HEALTH   (Thailand)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIN; ROTAVIRUS VACCINE; UNCLASSIFIED DRUG;

CHILDHOOD MORTALITY; CONFERENCE PAPER; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE POLICY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INTUSSUSCEPTION; PATHOGENESIS; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; ROTAVIRUS INFECTION; THAILAND; VACCINATION; VIRUS STRAIN; WORLD HEALTH ORGANIZATION;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; DIARRHEA; DRUG TOXICITY; GASTROENTERITIS; GENETIC VARIATION; HOSPITALIZATION; HUMANS; PRODUCT SURVEILLANCE, POSTMARKETING; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; THAILAND;

EID: 84874048440     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.12.148     Document Type: Conference Paper

References (25)

1. Bishop RF, Davidson GP, Holmes IH, Ruck BJ. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet 2(7841), 1281-1283 (1973).
2. Murphy TV, Gargiullo PM, Massoudi MS et al.; Rotavirus Intussusception Investigation Team. Intussusception among infants given an oral rotavirus vaccine. N. Engl. J. Med. 344(8), 564-572 (2001).
3. Vesikari T, Matson DO, Dennehy P et al.; Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med. 354(1), 23-33 (2006).
4. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR et al.; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med. 354(1), 11-22 (2006).
5. Madhi SA, Cunliffe NA, Steele D et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N. Engl. J. Med. 362(4), 289-298 (2010).
6. Armah GE, Sow SO, Breiman RF et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: A randomised, double-blind, placebo-controlled trial. Lancet 376(9741), 606-614 (2010).
7. Zaman K, Dang DA, Victor JC et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: A randomised, double-blind, placebo-controlled trial. Lancet 376(9741), 615-623 (2010).
8. Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI. Oral rotavirus vaccines: how well will they work where they are needed most? J. Infect. Dis. 200(Suppl. 1), S39-S48 (2009).
9. WHO. Meeting of the Strategic Advisory Group of Experts on immunization, October 2009-conclusions and recommendations. Wkly Epidemiol. Rec. 84(50), 518 (2009).
10. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: A systematic review and meta-analysis. Lancet Infect Dis. 12(2), 136-141 (2012).
11. Gladstone BP, Ramani S, Mukhopadhya I et al. Protective effect of natural rotavirus infection in an Indian birth cohort. N. Engl. J. Med. 365(4), 337-346 (2011).
12. Velázquez FR, Matson DO, Calva JJ et al. Rotavirus infections in infants as protection against subsequent infections. N. Engl. J. Med. 335(14), 1022-1028 (1996).
13. Lopman BA, Pitzer VE, Sarkar R et al. Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS One 7(8), e41720 (2012).
14. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N. Engl. J. Med. 362(4), 299-305 (2010).
15. Patel MM, Glass R, Desai R, Tate JE, Parashar UD. Fulfilling the promise of rotavirus vaccines: how far have we come since licensure? Lancet Infect. Dis. 12(7), 561-570 (2012).
16. Lopman BA, Curns AT, Yen C, Parashar UD. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J. Infect. Dis. 204(7), 980-986 (2011).
17. Patel MM, Clark AD, Sanderson CF, Tate J, Parashar UD. Removing the age restrictions for rotavirus vaccination: A benefit-risk modeling analysis. PLoS Med. 9(10), e1001330 (2012).
18. Bhandari N, Sharma P, Taneja S et al.; Rotavirus Vaccine Development Group. A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: A randomized, double-blind, placebo-controlled trial. J. Infect. Dis. 200(3), 421-429 (2009).
19. Dang DA, Nguyen VT, Vu DT et al.; Rotavin-M1 Vaccine Trial Group. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children. Vaccine 30(Suppl. 1), A114-A121 (2012).
20. Hu L, Crawford SE, Czako R et al. Cell attachment protein VP8*of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature 485(7397), 256-259 (2012).
21. Armah GE, Breiman RF, Tapia MD et al. Immunogenicity of the pentavalent rotavirus vaccine in African infants. Vaccine 30(Suppl. 1), A86-A93 (2012).
22. Shin S, Anh DD, Zaman K et al. Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam. Vaccine 30(Suppl. 1), A106-A113 (2012).
23. Hemming M, Vesikari T. Vaccine-derived human-bovine double reassortant rotavirus in infants with acute gastroenteritis. Pediatr. Infect. Dis. J. 31(9), 992-994 (2012).
24. Donato CM, Ch'ng LS, Boniface KF et al. Identification of strains of RotaTeq rotavirus vaccine in infants with gastroenteritis following routine vaccination. J. Infect. Dis. 206(3), 377-383 (2012).
25. Boom JA, Sahni LC, Payne DC et al. Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: A case series. J. Infect. Dis. 206(8), 1275-1279 (2012).